Related Experiment Video
Updated: Apr 17, 2026

Bacteriophage Effectiveness for Biocontrol of Foodborne Pathogens Evaluated via High-Throughput Settings
Published on: August 19, 2021
Targeting Enterococcus faecalis biofilms with phage therapy
Leron Khalifa1, Yair Brosh1, Daniel Gelman2
1Faculty of Dental Sciences, Hebrew University-Hadassah School of Dental Medicine, Jerusalem, Israel Department of Prosthodontics, Hebrew University-Hadassah School of Dental Medicine, Jerusalem, Israel.
Abstract:
Phage therapy has been proven to be more effective, in some cases, than conventional antibiotics, especially regarding multidrug-resistant biofilm infections. The objective here was to isolate an anti-Enterococcus faecalis bacteriophage and to evaluate its efficacy against planktonic and biofilm cultures. E. faecalis is an important pathogen found in many infections, including endocarditis and persistent infections associated with root canal treatment failure. The difficulty in E. faecalis treatment has been attributed to the lack of anti-infective strategies to eradicate its biofilm and to the frequent emergence of multidrug-resistant strains. To this end, an anti-E. faecalis and E. faecium phage, termed EFDG1, was isolated from sewage effluents. The phage was visualized by electron microscopy. EFDG1 coding sequences and phylogeny were determined by whole genome sequencing (GenBank accession number KP339049), revealing it belongs to the Spounavirinae subfamily of the Myoviridae phages, which includes promising candidates for therapy against Gram-positive pathogens. This analysis also showed that the EFDG1 genome does not contain apparent harmful genes. EFDG1 antibacterial efficacy was evaluated in vitro against planktonic and biofilm cultures, showing effective lytic activity against various E. faecalis and E. faecium isolates, regardless of their antibiotic resistance profile. In addition, EFDG1 efficiently prevented ex vivo E. faecalis root canal infection. These findings suggest that phage therapy using EFDG1 might be efficacious to prevent E. faecalis infection after root canal treatment.
Insights
Phage therapy using EFDG1 shows promise against multidrug-resistant Enterococcus faecalis infections. This bacteriophage effectively targets both planktonic cells and biofilms, offering a new strategy for difficult-to-treat conditions like root canal infections.
Area of Science:
- Microbiology
- Virology
- Infectious Diseases
Background:
- Enterococcus faecalis is a resilient pathogen causing infections like endocarditis and persistent root canal issues.
- Multidrug-resistant strains and robust biofilms present significant challenges for conventional antibiotic treatments.
- Effective anti-infective strategies are crucial for combating E. faecalis-associated infections.
Purpose of the Study:
- To isolate and characterize a bacteriophage targeting Enterococcus faecalis.
- To evaluate the efficacy of the isolated phage against planktonic and biofilm cultures of E. faecalis and E. faecium.
- To assess the phage's potential in preventing ex vivo E. faecalis root canal infections.
Main Methods:
- Isolation of bacteriophage EFDG1 from sewage effluents.
- Electron microscopy for phage visualization and whole genome sequencing for phylogenetic analysis.
- In vitro evaluation of EFDG1's lytic activity against planktonic and biofilm cultures of E. faecalis and E. faecium, including antibiotic-resistant strains.
- Ex vivo assessment of EFDG1 efficacy in preventing E. faecalis root canal infections.
Main Results:
- Bacteriophage EFDG1, belonging to the Myoviridae family, was isolated and characterized.
- EFDG1 demonstrated effective lytic activity against diverse E. faecalis and E. faecium isolates, irrespective of their antibiotic resistance.
- The phage efficiently prevented ex vivo E. faecalis root canal infections, indicating therapeutic potential.
Conclusions:
- Phage therapy with EFDG1 presents a viable alternative to antibiotics for treating E. faecalis infections.
- EFDG1 shows significant promise for preventing and treating persistent infections, particularly those involving biofilms and antibiotic resistance.
- The study highlights EFDG1 as a potential therapeutic agent for post-root canal treatment infections.
Related Concept Videos
Biofilms
Lytic Cycle of Bacteriophages
Biological Methods for Microbial Control
Gene Regulation in Microbial Communities: Quorum Sensing

